On Invalid Date, Frequency Therapeutics (NASDAQ: FREQ) reported Q3 2022 earnings per share (EPS) of -$0.55, up 24.66% year over year. Total Frequency Therapeutics earnings for the quarter were -$19.55 million. In the same quarter last year, Frequency Therapeutics's earnings per share (EPS) was -$0.73.
As of Q1 2023, Frequency Therapeutics's earnings has grown year over year. Frequency Therapeutics's earnings in the past year totalled -$85.72 million.
What is FREQ's earnings date?
Frequency Therapeutics's earnings date is Invalid Date. Add FREQ to your watchlist to be reminded of FREQ's next earnings announcement.
What was FREQ's revenue last quarter?
On Invalid Date, Frequency Therapeutics (NASDAQ: FREQ) reported Q3 2022 revenue of $0.00 up N/A year over year. In the same quarter last year, Frequency Therapeutics's revenue was $0.00.
What was FREQ's revenue growth in the past year?
As of Q1 2023, Frequency Therapeutics's revenue has grown -100% year over year. This is 216.99 percentage points lower than the US Biotechnology industry revenue growth rate of 116.99%. Frequency Therapeutics's revenue in the past year totalled $0.00.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.